SI-BONE (NASDAQ:SIBN) Upgraded at Zacks Investment Research
Zacks Investment Research upgraded shares of SI-BONE (NASDAQ:SIBN – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Friday, Zacks.com reports. According to Zacks, “SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint […]